WGIL News Audio: 7am News, Sports and Obits click HERE | For the latest WGIL news click HERE

City of Chicago Sues Over Painkiller Marketing

WGIL Newsroom . State News 126

CHICAGO (AP) — The city of Chicago has filed a lawsuit accusing five drugmakers of deceptively marketing a class of prescription painkiller that can be highly addictive.

The state lawsuit was filed Monday in Cook County Circuit Court. It alleges the companies’ marketing of opioids for long-term use to treat non-cancer pain was false, misleading and unsupported by science.

It’s similar to a lawsuit filed by two California counties last month. Both lawsuits name Johnson & Johnson’s Janssen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Teva Pharmaceutical Industries’ Cephalon Inc.

A Purdue spokesman says the company hasn’t received the complaint and has no comment. A Janssen spokeswoman says the company is committed to ethical business practices and responsible promotion of its medications. The other defendants haven’t responded to requests for comment.

All AP stories are Copyright 2014 by The Associated Press. All Rights Reserved.

The following provision applies to all visitors (which shall include persons and representatives of legal entities, whether such representatives are persons or digital engines of a kind that crawls, indexes, scrapes, copies, stores or transmits digital content). By accessing this Web site or digital service, you specifically acknowledge and agree that: (i) Associated Press text, photo, graphic, audio and/or video material shall not be published, broadcast, rewritten for broadcast or publication or redistributed directly or indirectly in any medium; (ii) No Associated Press materials nor any portion thereof may be stored in a computer except for personal and non-commercial use; (iii) The Associated Press will not be held liable for any delays, inaccuracies, errors or omissions therefrom or in the transmission or delivery of all or any part thereof or for any damages arising from any of the foregoing; (iv) The Associated Press is an intended third party beneficiary of these terms and conditions and it may exercise all rights and remedies available to it; and (v) The Associated Press reserves the right to audit possible unauthorized commercial use of AP materials or any portion thereof at any time.